Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

1.

Serum lipoprotein(a) in patients with diabetes mellitus.

Heller FR, Jamart J, Honore P, Derue G, Novik V, Galanti L, Parfonry A, Hondekijn JC, Buysschaert M.

Diabetes Care. 1993 May;16(5):819-23.

PMID:
8495624
[PubMed - indexed for MEDLINE]
2.

Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.

Chang CJ, Kao JT, Wu TJ, Lu FH, Tai TY.

Diabetes Care. 1995 Aug;18(8):1191-4.

PMID:
7587858
[PubMed - indexed for MEDLINE]
3.

Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?

Alagözlü H, Gültekin F, Candan F.

Nutr Metab Cardiovasc Dis. 2000 Aug;10(4):204-8.

PMID:
11079258
[PubMed - indexed for MEDLINE]
4.

A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.

Winocour PH, Durrington PN, Bhatnagar D, Mbewu AD, Ishola M, Mackness M, Arrol S.

Diabetes Res Clin Pract. 1992 Dec;18(3):173-84.

PMID:
1289018
[PubMed - indexed for MEDLINE]
5.

Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A.

Arch Intern Med. 2000 Oct 9;160(18):2756-62.

PMID:
11025785
[PubMed - indexed for MEDLINE]
6.

Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.

Hernández C, Chacón P, García-Pascual L, Simó R.

Diabetes Care. 2001 Feb;24(2):350-5.

PMID:
11213891
[PubMed - indexed for MEDLINE]
7.

Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.

Hirata K, Saku K, Jimi S, Kikuchi S, Hamaguchi H, Arakawa K.

Diabetologia. 1995 Dec;38(12):1434-42.

PMID:
8786017
[PubMed - indexed for MEDLINE]
8.

Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.

Wolffenbuttel BH, Leurs PB, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen Kruseman AC.

Diabet Med. 1993 Jun;10(5):427-30.

PMID:
8334821
[PubMed - indexed for MEDLINE]
9.

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

Diabetes Care. 1995 Aug;18(8):1113-23.

PMID:
7587846
[PubMed - indexed for MEDLINE]
10.

Biological variation of lipoprotein(a) in a diabetic population. Analysis of the causes and clinical implications.

Hernández C, Francisco G, Chacón P, Mesa J, Simó R.

Clin Chem Lab Med. 2003 Aug;41(8):1075-80.

PMID:
12964817
[PubMed - indexed for MEDLINE]
11.

The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.

Ko SH, Song KH, Ahn YB, Yoo SJ, Son HS, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK.

Metabolism. 2003 Jun;52(6):731-4.

PMID:
12800099
[PubMed - indexed for MEDLINE]
12.

The atherogenic lipid profile is associated with type 2 diabetes and some of its treatment modalities.

Lin M, Superko R, Williams P, Lim P, Pan J, Charles MA.

Diabetes Nutr Metab. 2003 Feb;16(1):56-64.

PMID:
12848306
[PubMed - indexed for MEDLINE]
13.

Lipoprotein(a) in diabetic patients with and without chronic renal failure.

Guillausseau PJ, Peynet J, Chanson P, Legrand A, Altman JJ, Poupon J, N'Guyen M, Rousselet F, Lubetzki J.

Diabetes Care. 1992 Aug;15(8):976-9.

PMID:
1387074
[PubMed - indexed for MEDLINE]
14.

Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

Diabetes Care. 1994 May;17(5):397-404.

PMID:
8062606
[PubMed - indexed for MEDLINE]
15.

Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.

Pedreño J, Fernández R, Ballester A, Jornet A, Usón M, Canela J, Petit M.

Int J Cardiol. 2000 Jul 31;74(2-3):159-67.

PMID:
10962116
[PubMed - indexed for MEDLINE]
16.

Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.

Wollesen F, Dahlén G, Berglund L, Berne C.

Diabetes Care. 1999 Jan;22(1):93-8.

PMID:
10333909
[PubMed - indexed for MEDLINE]
Free Article
17.

Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes.

Heesen BJ, Wolffenbuttel BH, Leurs PB, Sels JP, Menheere PP, Jäckle-Beckers SE, Nieuwenhuijzen Kruseman AC.

Eur J Clin Invest. 1993 Sep;23(9):580-4.

PMID:
8243530
[PubMed - indexed for MEDLINE]
18.

Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.

Hiraga T, Kobayashi T, Okubo M, Nakanishi K, Sugimoto T, Ohashi Y, Murase T.

Diabetes Care. 1995 Feb;18(2):241-4.

PMID:
7729305
[PubMed - indexed for MEDLINE]
19.

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes.

Haffner SM, Tuttle KR, Rainwater DL.

Metabolism. 1992 Feb;41(2):116-20.

PMID:
1531244
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk